Epinephrine Compositions and Containers
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 8 of these applications claim priority to application 62/647,303, filed Mar 23, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,653,646 | Epinephrine Compositions and Containers In force · High confidence | Nevakar Injectables Inc. | In force | High confidence | ||
| US 11,071,719 | Epinephrine Compositions and Containers In force · High confidence | Nevakar Injectables Inc. | In force | High confidence | ||
| US 11,083,698 | Epinephrine Compositions and Containers In force · High confidence | Nevakar Injectables Inc. | In force | High confidence | ||
| US 11,207,280 | Epinephrine Compositions and Containers In force · High confidence | Nevakar Injectables Inc. | In force | High confidence | ||
| US 12,133,837 | Epinephrine Compositions and Containers In force · Low confidence | Nevakar Injectables Inc. | In force | Low confidence | ||
| US 12,508,238 | Epinephrine Compositions and Containers In force · High confidence | Nevakar Injectables Inc. | In force | High confidence | ||
| US 12,533,328 | Epinephrine Compositions and Containers In force · High confidence | Nevakar Injectables Inc. | In force | High confidence | ||
| US 12,758,512 | Epinephrine Compositions and Containers In force · High confidence | Nevakar Injectables Inc. | In force | High confidence | ||
| Application 19/202,994 | Epinephrine Compositions and Containers Pending Not granted | Nevakar Injectables Inc. | Pending | Not granted |
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
8 of these are in force and held by Nevakar Injectables Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.